Drug detailer Caronia’s conviction is reversed by federal appeals court


The conviction of drug detailer Alfred Caronia, who admitted promoting unapproved uses for Orphan Medical Inc.’s Xyrem, was reversed yesterday by the U.S. Court of Appeals for the Second Circuit. “Although the FDA can continue to regulate false and misleading marketing by regulated companies, this decision likely will force serious reassessment of label-based restriction,” said John Kamp, Executive Director of the Coalition for Healthcare Communication. Read more from the Coalition, and find media coverage from Reuters, Pharmalot's Pharma Blog and Medical Marketing & Media.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Counsel, Regulatory (FDA)
San Diego , CA
Health Care Exchange Account Manager
Kaiser Permanente
San Diego, CA
Director, Health Plan Operations
Group Health Cooperative
Seattle, WA
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations